Medications

FDA approves new drug to protect against RSV in infants

Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year.

Neuroscience

Surprising plasticity in adult vision discovered

Much like young children who swiftly acquire languages in their early years, our visual system also has a "critical period" during the first few years of life where rapid development occurs. After this time, changes become ...

page 8 from 40